METHODS AND COMPOSITIONS FOR TREATING FIBROTIC LIVER CONDITIONS, USING UDENAFIL COMPOSITIONS

Various methods and compositions for using udenafil, or a pharmaceutical acceptable salt thereof, for improving enhanced liver fibrosis (ELF) score for improving, maintaining/stabilizing, preventing and/or reducing the rate of decline of fibrotic impaired liver function, transforming a fibrotic liver to a less fibrotic liver, maintaining fibrotic liver condition, and/or reversing fibrotic liver condition and function in patients who have fibrotic livers, especially patients having single ventricle heart disease (SVHD) who have undergone Fontan surgery and have Fontan physiology..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 16. Feb. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

GOLDBERG DAVID [VerfasserIn]
RUSSELL MARK [VerfasserIn]
SCHUMACHER KURT [VerfasserIn]
YEAGER JAMES [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-02-16, Last update posted on www.tib.eu: 2024-03-12, Last updated: 2024-03-15

Patentnummer:

CA3229274

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000475432